Literature DB >> 31588677

Phenotype and genotype of polycystic ovary syndrome in Asia: Ethnic differences.

Jin Ju Kim1,2, Young Min Choi2,3.   

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women, and ethnic diversity has been reported in its manifestation. This review addressed phenotype and genetic studies in Asian women with PCOS. Generally, East Asians are less hirsute, and the hirsutism score cutoff is lower than the Caucasian counterpart. It is not clear whether there are any significant differences in the prevalence or severity of irregular menstruation (IM) or characteristics of polycystic ovary (PCO) across ethnicities. Interestingly, the IM/PCO subgroup is a relatively common phenotype in East Asian patients but not in Caucasian patients. The prevalence of insulin resistance in PCOS patients varies depending on the index used and the cutoff, but women with PCOS showed a higher degree of insulin resistance than those of controls across ethnicities. Lower body mass index (BMI) and lower prevalence of metabolic syndrome were reported in East Asian patients, but despite lower BMI, a comparative study reported that Asian women with PCOS were more likely to have diabetes compared with Caucasian patients, suggesting they also have metabolic complications. Unlike East Asian patients, South Asian patients showed an increased degree of hirsutism, early onset of symptoms, and severe insulin resistance and metabolic risks compared with Caucasians. Genetic components play important roles in the pathogenesis of PCOS, and genome-wide association studies of PCOS suggest that similar genetic risk factors exist between Asian and Caucasian patients. Continuous comparative studies are needed to standardize the diagnosis and management of PCOS across different ethnicities.
© 2019 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  ethnicity; genetics; hirsutism; insulin resistance; polycystic ovary syndrome

Mesh:

Year:  2019        PMID: 31588677     DOI: 10.1111/jog.14132

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  7 in total

1.  The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome.

Authors:  Vu Ngoc Anh Ho; Toan Duong Pham; Nam Thanh Nguyen; Hieu Le Trung Hoang; Tuong Manh Ho; Lan Ngoc Vuong
Journal:  Clin Exp Reprod Med       Date:  2022-05-27

2.  Frequency of night shift and menstrual cycle characteristics in Japanese nurses working under two or three rotating shifts.

Authors:  Michinori Mayama; Takeshi Umazume; Hidemichi Watari; Sho Nishiguchi; Takuhiro Moromizato; Takashi Watari
Journal:  J Occup Health       Date:  2020-01       Impact factor: 2.708

3.  Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.

Authors:  Ying Xiong; Ce Bian; Xiaojuan Lin; Xiaoli Wang; Kehui Xu; Xia Zhao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

4.  Age-Adjusted Prevalence and Characteristics of Women with Polycystic Ovarian Syndrome in Korea: A Nationwide Population-Based Study (2010-2019).

Authors:  Ju Hee Kim; Min Hyung Jung; Se Hwa Hong; Nalae Moon; Dae Ryong Kang
Journal:  Yonsei Med J       Date:  2022-08       Impact factor: 3.052

5.  Is polycystic ovary syndrome undervalued in China?

Authors:  Xu Zheng; Chi Chiu Wang
Journal:  Lancet Reg Health West Pac       Date:  2022-06-27

6.  The Risks of Polycystic Ovary Syndrome and Diabetes Vary by Ethnic Subgroup Among Young Asian Women.

Authors:  Lynn Guo; Nancy P Gordon; Malini Chandra; Olumayowa Dayo; Joan C Lo
Journal:  Diabetes Care       Date:  2021-04-26       Impact factor: 19.112

7.  Obesity and risk of female reproductive conditions: A Mendelian randomisation study.

Authors:  Samvida S Venkatesh; Teresa Ferreira; Stefania Benonisdottir; Nilufer Rahmioglu; Christian M Becker; Ingrid Granne; Krina T Zondervan; Michael V Holmes; Cecilia M Lindgren; Laura B L Wittemans
Journal:  PLoS Med       Date:  2022-02-01       Impact factor: 11.613

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.